VICTORIA CARTER: Open Payments
NPI 1871204313 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 41 payments from 18 companies in 2025. Trend: 2023 $3,610 · 2024 $2,983 · 2025 $986
Food & beverage: $986
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 4 | $190 |
| AstraZeneca Pharmaceuticals LP | 9 | $184 |
| Merck Sharp & Dohme LLC | 3 | $97 |
| Verona Pharma, Inc. | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| GENZYME CORPORATION | 2 | $45 |
| United Therapeutics Corporation | 2 | $44 |
| Insmed, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Inspire Medical Systems, Inc. | 2 | $31 |
Products named: TERLIVAZ, FASENRA, DUPIXENT, Ohtuvayre, TEZSPIRE, ACTHAR, WINREVAIR, Tyvaso.
Industry payments across AL — which companies pay providers there.
